Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Actavis launches Finasteride in 14 European countries
June 27th, 2007
Actavis today announced the launch of Finasteride tablets in 14 European countries. The distribution of the product has already commenced. Actavis has already had well over 100 product and market launches this year, and before year end more than 500 launches will be completed. Finasteride was launched as the patent protection expired in the UK, the Netherlands, Germany and Denmark. Actavis currently sells the product under its own label in 12 countries, both in Europe and in the US. Actavis' Third Party division sells the product to a number of its customers in eight countries. Finasteride is a new molecule in Actavis' portfolio this year and is...
Source: Medical Patent Law Weekly (2007-06-27)
|
